{"id":"https://openalex.org/W4362575234","doi":"https://doi.org/10.1016/j.ijpharm.2023.122917","title":"Formulation, and optimization of transdermal Atorvastatin Calcium-Loaded Ultra-flexible vesicles; ameliorates poloxamer 407-caused dyslipidemia","display_name":"Formulation, and optimization of transdermal Atorvastatin Calcium-Loaded Ultra-flexible vesicles; ameliorates poloxamer 407-caused dyslipidemia","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362575234","doi":"https://doi.org/10.1016/j.ijpharm.2023.122917","pmid":"https://pubmed.ncbi.nlm.nih.gov/37019321"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2023.122917","doi":"https://doi.org/10.1016/j.ijpharm.2023.122917","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2023.122917","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053819804","display_name":"Mohamed A. Akl","orcid":"https://orcid.org/0000-0002-9764-1730","observed_orcids":["https://orcid.org/0000-0002-9764-1730"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4405259362","display_name":"Islamic University of Najaf","ror":"https://ror.org/024dzaa63","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4405259362"]}],"countries":["EG","IQ"],"is_corresponding":true,"raw_author_name":"Mohamed A. Akl","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, The Islamic University, Najaf 54001, Iraq. Electronic address: mohamedakl@Azhar.edu.eg","Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt","Department of Pharmaceutics, Faculty of Pharmacy, The Islamic University, Najaf 54001, Iraq"],"raw_orcid":"https://orcid.org/0000-0002-9764-1730","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, The Islamic University, Najaf 54001, Iraq. Electronic address: mohamedakl@Azhar.edu.eg","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4405259362"]},{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]},{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, The Islamic University, Najaf 54001, Iraq","institution_ids":["https://openalex.org/I4405259362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084017341","display_name":"Sherif Ryad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Sherif Ryad","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022656184","display_name":"Mohamed F. Ibrahim","orcid":"https://orcid.org/0000-0002-9239-7142","observed_orcids":["https://orcid.org/0000-0002-9239-7142"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohamed F. Ibrahim","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112548334","display_name":"Alaa A. Kassem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Alaa A. Kassem","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053819804"],"corresponding_institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4405259362"],"apc_list":{"value":4050,"currency":"USD","value_usd":4050},"apc_paid":null,"fwci":2.5243,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.88888889,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"638","issue":null,"first_page":"122917","last_page":"122917"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin-calcium","display_name":"atorvastatin calcium","score":0.9879999756813049},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.9459999799728394},{"id":"https://openalex.org/keywords/transfersomes","display_name":"transfersomes","score":0.6690000295639038},{"id":"https://openalex.org/keywords/pluronic-f127","display_name":"Pluronic F127","score":0.9670000076293945},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.7200000286102295},{"id":"https://openalex.org/keywords/edge-activators","display_name":"edge activators","score":0.8730000257492065},{"id":"https://openalex.org/keywords/phosphatidylcholine","display_name":"phosphatidylcholine","score":0.9570000171661377},{"id":"https://openalex.org/keywords/transdermal-gel","display_name":"transdermal gel","score":0.5899999737739563},{"id":"https://openalex.org/keywords/bioavailability-enhancement","display_name":"bioavailability enhancement","score":0.6359999775886536},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6660000085830688},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6710000038146973},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.777999997138977},{"id":"https://openalex.org/keywords/statin-induced-liver-injury","display_name":"statin-induced liver injury","score":0.503000020980835},{"id":"https://openalex.org/keywords/hypolipidemic-activity","display_name":"hypolipidemic activity","score":0.8059999942779541},{"id":"https://openalex.org/keywords/vesicle-formulation-optimization","display_name":"vesicle formulation optimization","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7947591543197632},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.7928286790847778},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.7432457208633423},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6943249702453613},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.665625810623169},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6599883437156677},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5625590682029724},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.5083712935447693},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.5013790130615234},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4843910336494446},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4514651298522949},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.4252112805843353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2173621654510498},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11679017543792725},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09188324213027954},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054709","descriptor_name":"Lecithins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ijpharm.2023.122917","doi":"https://doi.org/10.1016/j.ijpharm.2023.122917","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2023.122917","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:37019321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37019321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W153019464","https://openalex.org/W1540384225","https://openalex.org/W1982181124","https://openalex.org/W1992527461","https://openalex.org/W1993002471","https://openalex.org/W1993345773","https://openalex.org/W2010311410","https://openalex.org/W2020006462","https://openalex.org/W2024007314","https://openalex.org/W2033416281","https://openalex.org/W2054872615","https://openalex.org/W2055400540","https://openalex.org/W2061444430","https://openalex.org/W2064269909","https://openalex.org/W2075520799","https://openalex.org/W2076396960","https://openalex.org/W2085496520","https://openalex.org/W2086889742","https://openalex.org/W2089712819","https://openalex.org/W2102109292","https://openalex.org/W2104187915","https://openalex.org/W2161530911","https://openalex.org/W2185501095","https://openalex.org/W2187577977","https://openalex.org/W2222861502","https://openalex.org/W2302195065","https://openalex.org/W2323884957","https://openalex.org/W2326507095","https://openalex.org/W2328614343","https://openalex.org/W2508207342","https://openalex.org/W2513085819","https://openalex.org/W2603978658","https://openalex.org/W2606074773","https://openalex.org/W2616126002","https://openalex.org/W2782690276","https://openalex.org/W2790036073","https://openalex.org/W2794357163","https://openalex.org/W2794600554","https://openalex.org/W2804846127","https://openalex.org/W2889932786","https://openalex.org/W2891987281","https://openalex.org/W2896205210","https://openalex.org/W2912111325","https://openalex.org/W2937737033","https://openalex.org/W2998685512","https://openalex.org/W3023383116","https://openalex.org/W3028959239","https://openalex.org/W3047428985","https://openalex.org/W3083987393","https://openalex.org/W3088916776","https://openalex.org/W3092849554","https://openalex.org/W3112689703","https://openalex.org/W3124563177","https://openalex.org/W3142840603","https://openalex.org/W3186211590","https://openalex.org/W3196815869","https://openalex.org/W3197402469","https://openalex.org/W3201601961","https://openalex.org/W4205559538","https://openalex.org/W4210379198","https://openalex.org/W4211265440","https://openalex.org/W4220754795","https://openalex.org/W4225419018"],"related_works":["https://openalex.org/W2603978658","https://openalex.org/W3196815869","https://openalex.org/W4402460185","https://openalex.org/W3112689703","https://openalex.org/W4403904283","https://openalex.org/W4403609199","https://openalex.org/W3082836341","https://openalex.org/W3002834369","https://openalex.org/W4407425065","https://openalex.org/W4416008804"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}